BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND HOXD11, ENSG00000128713, 3237 AND Diagnosis
5 results:

  • 1. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study.
    Karagiannidis C; Mostert C; Hentschker C; Voshaar T; Malzahn J; Schillinger G; Klauber J; Janssens U; Marx G; Weber-Carstens S; Kluge S; Pfeifer M; Grabenhenrich L; Welte T; Busse R
    Lancet Respir Med; 2020 Sep; 8(9):853-862. PubMed ID: 32735842
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome.
    Ortolan E; Giacomino A; Martinetto F; Morone S; Lo Buono N; Ferrero E; Scagliotti G; Novello S; Orecchia S; Ruffini E; Rapa I; Righi L; Volante M; Funaro A
    Oncotarget; 2014 Aug; 5(15):6191-205. PubMed ID: 25026285
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Utilisation of radiotherapy in rural and urban areas in British Columbia compared with evidence-based estimates of radiotherapy needs for patients with breast, prostate and lung cancer.
    Tyldesley S; McGahan C
    Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):526-32. PubMed ID: 20594811
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cutting needle biopsy in the diagnosis of clinically suspected non-carcinomatous disease of the lung.
    Bungay HK; Adams RF; Morris CM; Haggett PJ; Traill ZC; Gleeson FV
    Br J Radiol; 2000 Apr; 73(868):349-55. PubMed ID: 10844858
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. How should cancer presenting as a malignant pleural effusion be managed?
    Bonnefoi H; Smith IE
    Br J Cancer; 1996 Sep; 74(5):832-5. PubMed ID: 8795590
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.